Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 19 pseudogene 6 (KRT19P6) is a noncoding genomic sequence classified as a processed pseudogene within the type I keratin family[4][5]. It shares sequence homology with the functional keratin 19 gene (KRT19), but it does not code for a functional protein and has no established biological function, disease association, or therapeutic relevance. Pseudogenes like KRT19P6 may potentially influence gene regulation through noncoding RNA interactions, but no specific function has been demonstrated for KRT19P6. In clinical diagnostics, sequence similarity to KRT19 can lead to false-positive results when using nucleic-acid-based assays to detect KRT19 expression; this is a consideration for assay design and interpretation rather than a safety or therapeutic challenge[1][5]. KRT19P6 is a validated pseudogene in the human genome, not a molecular target, receptor, enzyme, transporter, or marker for therapeutic intervention. Its importance is limited to genomic studies and consideration as a confounder in assays targeting its parental gene, KRT19.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 19 pseudogene 6 (KRT19P6).